Seibel, Ira
Vollhardt, Daniela
Riechardt, Aline I.
Rehak, Matus
Schmied, Sabine
Schiller, Petra
Zeitz, Oliver
Hellmich, Martin
Joussen, Antonia M.
Funding for this research was provided by:
Novartis Pharma
Article History
Received: 29 July 2019
Revised: 23 January 2020
Accepted: 2 February 2020
First Online: 28 February 2020
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: I.S.: payment for development of educational presentations (Novartis Pharma GmbH, Nürnberg, Germany, Pharm-Allergan GmbH, Frankfurt am Main, Germany, Bayer AG, Leverkusen, Germany) outside the submitted work; D.V.: none; A.I.R.: none; M.R.: grants from Novartis Pharma, during the conduct of the study; grants and personal fees from Novartis Pharma, personal fees from Bayer Vital, personal fees from Allergan, personal fees from Alimera Sciences, personal fees from Zeiss, personal fees from Heidelberg Engineering, outside the submitted work; S.S.: none; P.S.: none; O.Z.: personal fees from Bayer AG, grants from Novartis, personal fees from Boehringer Ingelheim, outside the submitted work; A.M.J.: payment for development of educational presentations (Novartis Pharma GmbH, Nürnberg, Germany) and travel/accommodations/meeting expenses (Novartis Pharma GmbH, Nürnberg, Germany, Alcon Pharma GmbH Freiburg im Breisgau, Germany, and Pharm-Allergan GmbH, Frankfurt am Main, Germany).